A recent study on Novo Nordisk's weight-loss medication, Wegovy, has shown promising results, helping 40% of young children overcome obesity. This trial marks the first time researchers have specifically evaluated the drug's effectiveness in a younger age group.
While earlier clinical trials had already established that Wegovy successfully helps older children lose weight, these new findings expand the evidence base for potential treatments targeting childhood obesity in younger populations.
Source Attribution: Article content originally reported by Business Standard; Bloomberg. Read original story coverage on Business Standard; Bloomberg →
